{"Ticker": "MCK", "Company": "McKesson Corporation", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-06-07", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$343 to $378"}, {"Date": "2022-04-01", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$333"}, {"Date": "2022-02-04", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$262 to $270"}, {"Date": "2022-01-07", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Outperform", "Target_Change": ""}, {"Date": "2021-11-02", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$270 to $280"}, {"Date": "2021-11-02", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$225 to $230"}, {"Date": "2021-11-02", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$237 to $250"}, {"Date": "2021-11-02", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$255 to $270"}, {"Date": "2021-03-30", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": "$230"}, {"Date": "2020-11-02", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$166"}, {"Date": "2020-08-04", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$202"}, {"Date": "2020-05-22", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": ""}, {"Date": "2020-05-15", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$151 to $160"}, {"Date": "2020-04-23", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$146"}, {"Date": "2020-03-18", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$173 to $174"}, {"Date": "2020-03-13", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2020-02-07", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$197"}, {"Date": "2020-01-10", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$162"}, {"Date": "2019-09-12", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2019-08-05", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2019-07-22", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": "$152"}, {"Date": "2019-01-17", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$134"}, {"Date": "2018-10-26", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$150 to $136"}, {"Date": "2018-07-20", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": ""}]}